2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Autor:	Fukunaga, Kenji, Uehara, Fumiaki, Aritomo, Keiichi, Shoda, Aya, Hiki, Shinsuke, Okuyama, Masahiro, Usui, Yoshihiro, Watanabe, Kazutoshi, Yamakoshi, Koichi, Kohara, Toshiyuki, Hanano, Tokushi, Tanaka, Hiroshi, Tsuchiya, Susumu, Sunada, Shinji, Saito, Ken-Ichi, Eguchi, Jun-ichi, Yuki, Satoshi, Asano, Shoichi, Tanaka, Shinji, Mori, Akiko, Yamagami, Keiji, Baba, Hiroshi, Horikawa, Takashi, Fujimura, Masatake
Zdroj:	In Bioorganic & Medicinal Chemistry Letters 15 December 2013 23(24):6933-6937
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect